Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesNifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation
Biochemical and Biophysical Research Communications, 06/16/09
Matsui T et al. - The authors present study provides a unique beneficial aspect of nifedipine on diabetic nephropathy; it could work as an anti-inflammatory agent against AGE by suppressing RAGE expression in cultured mesangial cells via PPAR-gamma activation.
Related Articles
Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetes
Diabetes Care, 10/28/09
Relevance Score: 69%
The V16A polymorphism in SOD2 is associated with increased risk of diabetic nephropathy and cardiovascular disease in type 1 diabetes
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 11/06/09
Relevance Score: 68%
Nephropathy in Type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivity
Platelets, 10/30/09
Relevance Score: 68%
Which components of malnutrition–inflammation–atherosclerosis syndrome are more common in haemodialysis patients with diabetic nephropathy
Nephrology, 10/06/09
Relevance Score: 68%
Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy
Hypertension Research, 11/09/09
Relevance Score: 67%
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Stone composition and metabolic status
Urological Research - Urolithiasis, 11/25/09
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09
Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
Journal of the American Society of Nephrology, 11/20/09
Today in Nephropathies...keeping you current
Receive free subspecialty "5-minute updates" via email
Association of the PPARGC1A Gene Polymorphism With Diabetic Nephropathy in an Asian Indian Population (CURES-41)
Metabolic Syndrome and Related Disorders, 11/25/09
Ultrastructural changes in the glomerular filtration barrier and occurrence of proteinuria in Chinese patients with type 2 diabetic nephropathy
Diabetes Research and Clinical Practice, 11/25/09
Efficacy and safety of angiotensin II receptor type 1 antagonists in children and adolescents
Pediatric Nephrology, 11/23/09
Article Search
Sponsor